loading

Zevra Therapeutics Inc Borsa (ZVRA) Ultime notizie

pulisher
Sep 06, 2025

Is Zevra Therapeutics Inc. stock a good dividend stockWeekly Trading Summary & Technical Pattern Alert System - خودرو بانک

Sep 06, 2025
pulisher
Sep 06, 2025

Is Zevra Therapeutics Inc. a strong growth stockWeekly Trade Report & Low Drawdown Momentum Trade Ideas - خودرو بانک

Sep 06, 2025
pulisher
Sep 05, 2025

What’s the recovery path for long term holders of Zevra Therapeutics Inc.Market Activity Recap & Free Community Consensus Stock Picks - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Is Zevra Therapeutics Inc. a good ESG investmentGap Down & Free Verified High Yield Trade Plans - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

What analysts say about Zevra Therapeutics Inc. stockWeekly Profit Report & High Return Trade Opportunity Guides - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Quantitative breakdown of Zevra Therapeutics Inc. recent moveQuarterly Investment Review & Long-Term Safe Return Strategies - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Measuring Zevra Therapeutics Inc.’s beta against major indicesMarket Weekly Review & Precise Swing Trade Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Using Python tools to backtest Zevra Therapeutics Inc. strategiesMarket Performance Summary & Advanced Technical Analysis Signals - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Zevra Therapeutics Inc. stock retracement – recovery analysisSell Signal & Safe Entry Momentum Tips - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Using data models to predict Zevra Therapeutics Inc. stock movementStock Surge & Free Technical Confirmation Trade Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Does Zevra Therapeutics Inc. qualify in momentum factor screeningWeekly Profit Report & Expert Curated Trade Setup Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Volume spikes in Zevra Therapeutics Inc. stock – what they meanTrade Risk Report & Safe Entry Trade Signal Reports - Newser

Sep 05, 2025
pulisher
Sep 04, 2025

What recovery options are there for Zevra Therapeutics Inc.July 2025 Market Mood & Reliable Entry Point Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Zevra Therapeutics Presents Positive New Data Supporting - GlobeNewswire

Sep 04, 2025
pulisher
Sep 04, 2025

Disease Progression Slowed: Zevra's MIPLYFFA Shows Breakthrough Results in Rare Niemann-Pick Disease Trial - Stock Titan

Sep 04, 2025
pulisher
Sep 04, 2025

How does Zevra Therapeutics Inc. compare to its peersMarket Sentiment Review & AI Driven Stock Price Forecasts - خودرو بانک

Sep 04, 2025
pulisher
Sep 04, 2025

What makes Zevra Therapeutics Inc. stock price move sharplyJuly 2025 Review & Expert Approved Momentum Ideas - Newser

Sep 04, 2025
pulisher
Sep 03, 2025

Tools to monitor Zevra Therapeutics Inc. recovery probabilityEarnings Growth Report & High Return Stock Watch Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can you recover from losses in Zevra Therapeutics Inc.Weekly Market Report & Low Drawdown Momentum Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Zevra Therapeutics at Cantor Conference: Rare Disease Strategy Unveiled By Investing.com - Investing.com Canada

Sep 03, 2025
pulisher
Sep 03, 2025

Fund Flows: What is Zevra Therapeutics Inc.’s market positionProfit Target & Fast Momentum Stock Entry Tips - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

Zevra Therapeutics at Cantor Conference: Rare Disease Strategy Unveiled - Investing.com

Sep 03, 2025
pulisher
Sep 03, 2025

Does Zevra Therapeutics Inc. meet Warren Buffett’s criteria2025 Market Overview & Weekly Chart Analysis and Trade Guides - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

Predicting Zevra Therapeutics Inc. trend using moving averages2025 Growth vs Value & AI Enhanced Trading Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Zevra Therapeutics Inc. stock chart pattern explained2025 Retail Activity & Verified Entry Point Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How to manage a losing position in Zevra Therapeutics Inc.2025 Winners & Losers & Fast Exit and Entry Strategy Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can Zevra Therapeutics Inc. recover in the next quarterChart Signals & Community Trade Idea Sharing Platform - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Relative strength of Zevra Therapeutics Inc. in sector analysisTrade Risk Summary & Comprehensive Market Scan Insights - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Zevra Therapeutics Inc. still worth holding after the dipJuly 2025 Decliners & Smart Investment Allocation Insights - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Full technical analysis of Zevra Therapeutics Inc. stock2025 Key Highlights & Reliable Price Breakout Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Advanced analytics toolkit walkthrough for Zevra Therapeutics Inc.Jobs Report & Growth Oriented Trading Recommendations - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

How to build a dashboard for Zevra Therapeutics Inc. stockWeekly Stock Report & Short-Term High Return Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Zevra Therapeutics gains amid takeover speculation - MSN

Sep 02, 2025
pulisher
Sep 02, 2025

Is now a turning point for Zevra Therapeutics Inc.Market Risk Summary & Free Low Drawdown Momentum Trade Ideas - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Is Zevra Therapeutics Inc. stock overhyped or has real potentialMarket Activity Summary & Real-Time Stock Price Movement Reports - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Custom strategy builders for tracking Zevra Therapeutics Inc.2025 Buyback Activity & Fast Gain Stock Trading Tips - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Is Zevra Therapeutics Inc. stock bottoming outJuly 2025 Decliners & AI Optimized Trading Strategy Guides - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Real time scanner hits for Zevra Therapeutics Inc. explainedQuarterly Growth Report & Capital Efficient Trade Techniques - Newser

Sep 01, 2025
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):